| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bluejay Diagnostics, Inc. (BJDX) has 0 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. BJDX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | Dey Indranil | President And CEO | Buy | 500 | $3.27 | $1,635.00 | +1.8% | |
| Dec 13, 2023 | Dey Svetlana | Director | Buy | 500 | $3.07 | $1,535.00 | +50.0% | |
| Aug 26, 2022 | Fisher Kenneth R | Chief Financial Officer | Buy | 20,000 | $1.03 | $20,600.00 | +100.0% | |
| Apr 25, 2022 | Fisher Kenneth R | Chief Financial Officer | Buy | 20,000 | $0.99 | $19,800.00 | New | |
| Mar 17, 2022 | Wurth Douglas Clark | Director, 10% Owner | Buy | 40,000 | $1.18 | $47,120.00 | +1.8% | |
| Mar 17, 2022 | Kinder Gordon Winston | Chief Financial Officer | Buy | 2,500 | $1.16 | $2,897.50 | +15.6% | |
| Mar 17, 2022 | Dey Svetlana | Director, 10% Owner | Buy | 10,000 | $1.18 | $11,830.00 | New | |
| Mar 16, 2022 | Wurth Douglas Clark | Director, 10% Owner | Buy | 60,000 | $1.09 | $65,400.00 | +2.7% | |
| Mar 16, 2022 | Kinder Gordon Winston | Chief Financial Officer | Buy | 16,000 | $0.97 | $15,530.00 | +74.4% |